BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 395437)

  • 1. [A case of Louis-Bar syndrome. Diagnostic problems and therapeutic prospects].
    Colonna F; Bonassi E; Beatrice M; Rinone R; Tovo PA
    Minerva Pediatr; 1979 Sep; 31(17):1267-71. PubMed ID: 395437
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ataxia telangiectasia or the Louis-Bar syndrome. Case reports].
    Vallarino G; Rainero L; Fregonese B; Merlini M; Zappa GP
    Minerva Pediatr; 1976 Mar; 28(7):407-11. PubMed ID: 1004438
    [No Abstract]   [Full Text] [Related]  

  • 3. Thymosin treatment of children with primary immunodeficiency disease.
    Wara DW; Ammann AJ
    Transplant Proc; 1978 Mar; 10(1):203-9. PubMed ID: 305674
    [No Abstract]   [Full Text] [Related]  

  • 4. Thymopoietin pentapeptide treatment of primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Rossi P; Seminara R; Goldstein G
    Lancet; 1983 Mar; 1(8324):551-4. PubMed ID: 6131256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of the immunological deficiency in ataxia-telangiectasia: absence of a clinical-pathological correlation.
    Roifman CM; Gelfand EW
    Kroc Found Ser; 1985; 19():273-85. PubMed ID: 3877786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of synthetic thymic hormone (TP5) in children with T-cell immunodeficiencies.
    Levinsky RJ; Davies EG; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):273-6. PubMed ID: 6360239
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy with thymopoietin pentapeptide (TP-5) in 26 patients with primary immunodeficiencies.
    Aiuti F; Businco L; Fiorilli M; Galli E; Quinti I; Le Moli S; Seminara R; Goldstein G
    Birth Defects Orig Artic Ser; 1983; 19(3):267-72. PubMed ID: 6360238
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinico-immunologic indices in patients with the Louis-Bar syndrome following transplantation of the thymus and sternum].
    Lopukhin IuM; Morozov IuI; Kalinina LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(10):1484-91. PubMed ID: 4590542
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of natural killer activity and of T cells after thymopoietin pentapeptide therapy in a patient with severe combined immunodeficiency.
    Fiorilli M; Sirianni MC; Pandolfi F; Quinti I; Tosti U; Aiuti F; Goldstein G
    Clin Exp Immunol; 1981 Aug; 45(2):344-51. PubMed ID: 7032772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to thymopoietin pentapeptide in patient with DiGeorge syndrome.
    Aiuti F; Businco L; Rossi P; Quinti I
    Lancet; 1980 Jan; 1(8159):91. PubMed ID: 6101433
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantified deficiency of lymphocyte response to phytohaemagglutinin in immune deficiency diseases.
    Hosking CS; Fitzgerald MG; Simons MJ
    Clin Exp Immunol; 1971 Oct; 9(4):467-76. PubMed ID: 5123224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of thymic humoral factor on cellular immune factors of normal children and of pediatric patients with ataxia telangiectasia and Down's syndrome.
    Handzel ZT; Dolfin Z; Levin S; Altman Y; Hahn T; Trainin N; Gadot N
    Pediatr Res; 1979 Jul; 13(7):803-6. PubMed ID: 158166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The thymus in immunodeficiency diseases: new therapeutic approaches.
    Bach JF
    Birth Defects Orig Artic Ser; 1983; 19(3):245-53. PubMed ID: 6360235
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thymopentin and immune response in patients with cancer].
    Petronella P; Ferrone R; Freda F; Valeriani G
    Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ataxia-telangiectasia. (Clinical and immunological aspects).
    Boder E; Sedgwick RP
    Psychiatr Neurol Med Psychol Beih; 1970; 13-14():8-16. PubMed ID: 5006295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thymopentin (TP-5) in the treatment of the postburn and postoperative immunodeficiency syndrome.
    Hamilton G; Zöch G; Rath T; Meissl G
    Prog Clin Biol Res; 1989; 308():995-9. PubMed ID: 2528748
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ataxia telangiectasia (Louis-Bar syndrome)].
    Gschnait F; Grabner G; Brenner W; Tappeiner J
    Hautarzt; 1979 Oct; 30(10):527-31. PubMed ID: 521274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological studies in ataxia-telangiectasia.
    Kiran O; Yalaz K; Taysi K; Say B
    Clin Genet; 1974 Jan; 5(1):40-5. PubMed ID: 4599963
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical-immunological study and transplantation of the thymus in the Louis-Bar syndrome].
    Lopukhin IuM; Badalian LO; Morozov IuI; Kalinina LV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(10):1466-70. PubMed ID: 5139407
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ataxia with telangiectasia--the Louis-Bar syndrome].
    Machula F; Schwartzová K; Amblerová V; Losan F
    Cesk Neurol Neurochir; 1981 Sep; 44(5):320-7. PubMed ID: 7307153
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.